Anthem Biosciences Closes Trading Window for Q2FY27
Anthem Biosciences Ltd has announced the closure of its trading window for designated persons from October 01, 2026, until 48 hours after the board meeting to approve financial results for the quarter and half-year ending September 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. All designated persons are prohibited from trading in the company's securities during this period. The date of the board meeting will be communicated separately.
Key Highlights
- Trading window closed for designated persons from Oct 01, 2026.
- Closure is for Q2FY27 financial results approval.
- Effective until 48 hours post-board meeting.
- Aims to prevent insider trading as per SEBI regulations.
Price Impact
More from ANTHEM
Anthem Biosciences Settles Upside Sharing Arrangement for ₹1,276.83 Million
Anthem Biosciences Q1FY27 Revised Results: Revenue ₹4,182 Mn, PAT ₹1,199 Mn
Anthem Biosciences Q1FY27 Revenue ₹4,182 Mn, PAT ₹1,199 Mn